We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Par Pharmaceutical Loses Dispute With Pentech in Generic Paxil Case
Par Pharmaceutical Loses Dispute With Pentech in Generic Paxil Case
February 17, 2009
Par Pharmaceutical is considering its legal options after an Illinois judge ruled against the company in a contract dispute with Pentech Pharmaceuticals over a generic version of GlaxoSmithKline’s (GSK) antidepressant Paxil.